Earnings
PHAR
14.50
-0.97%
-0.14
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2019-12-31
74.32M
--
--
24.02M
--
--
2.28M
--
16.22M
--
2.55M
--
119.39M
16.29M
--
6.17M
--
--
79.38M
--
34.59M
136.43M
255.82M
--
6.00M
0.00
--
--
--
--
--
-234.29K
--
--
--
55.16M
114.21M
4.89M
--
--
--
19.37M
24.26M
138.48M
7.08M
439.73M
-329.46M
--
--
--
117.35M
117.35M
255.82M
FY 2018-12-31
92.06M
--
--
17.58M
--
--
763.44K
--
19.85M
--
2.08M
--
132.33M
9.63M
--
0.00
--
--
60.11M
--
43.79M
113.53M
245.86M
--
7.61M
0.00
--
--
--
--
--
2.46M
--
--
--
43.92M
94.68M
42.91M
--
--
--
37.49M
80.39M
175.08M
7.12M
444.22M
-380.56M
--
--
--
70.79M
70.79M
245.86M
FY 2017-12-31
70.72M
--
--
10.72M
--
--
1.55M
--
22.11M
--
1.30M
--
106.40M
9.93M
--
--
--
--
68.28M
--
15.76M
93.97M
200.38M
--
11.37M
0.00
--
--
--
--
--
0.00
--
--
--
34.55M
73.24M
71.80M
--
--
0.00
35.91M
107.71M
180.95M
6.98M
438.66M
-426.21M
--
--
--
19.42M
19.42M
200.38M
FY 2016-12-31
33.63M
--
--
6.62M
--
--
5.38M
--
18.92M
--
1.03M
--
65.59M
6.37M
--
--
--
--
59.77M
--
1.97M
68.12M
133.71M
--
5.96M
0.00
--
--
--
--
--
229.90K
--
--
--
20.15M
54.18M
43.23M
--
--
--
7.32M
50.56M
104.74M
4.80M
318.36M
-294.20M
--
--
--
28.97M
28.97M
133.71M
FY 2015-12-31
34.37M
--
--
2.29M
--
--
963.46K
--
17.63M
--
246.57K
--
55.50M
6.15M
--
--
--
--
786.41K
--
217.24K
7.15M
62.65M
--
1.10M
0.00
--
--
--
--
--
203.12K
--
--
--
9.73M
14.64M
13.64M
--
--
--
8.48M
22.12M
36.75M
4.48M
307.82M
-286.41M
--
--
--
25.89M
25.89M
62.65M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out PHAR latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze Pharming Group N.V. recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.